Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension. (Image Credits: Pixabay) Alembic Pharmaceuticals Limited on Monday announced that it has received ...

Generic drugmaker Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for Diltiazem Hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. A ...

The Food and Drug Administration has given Alembic permission for diltiazem hydrochloride extended-release capsules, 120 mg, 180 mg, 240 mg, 300 mg and 360 mg., which is the generic of Bausch Health's ...

Zydus Lifesciences Limited announced it has received final approval from the United States Food and Drug Administration (USFDA) for Diltiazem Hydrochloride Tablets USP, in strengths of 30 mg, 60 mg, ...

MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its ...

Alembic Pharmaceuticals stated that it gained final FDA approval for the Diltiazem Hydrochloride Extended-Release capsules, which are used to treat hypertension. Alembic Pharma reported in a stock ...

Alembic Pharmaceuticals Share Price | The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. Alembic Pharmaceuticals share price rose 2 percent ...